Neuroprosthetics Market Driven by Advancements in Technology and Rising Neurological Disorders

Global neuroprosthetics market is anticipated to grow at a CAGR of 12.7% during the forecast period (2024–2031). Neuroprosthetics uses electrodes to interface with the central or peripheral nervous system to restore lost motor or sensory capabilities. These devices can receive neural signals from the external environment and brain, and convert the signals to restore functions such as loss of hearing and vision. They have applications in cognitive disorders, ophthalmic disorders, motor disorders, and auditory disorders. The major factors driving the growth of this market are the increasing number of patients suffering from neurological disorders and nerve injury, the growing incidence of hearing loss, increasing cases of amputations due to the rising number of accidents and injuries, and the increasing incidence of diabetes.

Browse the full report description of “Neuroprosthetics Market Size, Share & Trends Analysis Report by Type (Motor Prosthetics, Sensory Prosthetics, Cognitive Prosthetics, and Visual Prosthetics), by Treatment Technique (Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulator (SNS), and Spinal Cord Stimulator (SCS) and by Application (Motor Disorder, Physiological Disorder, and Cognitive Disorder) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/neuroprosthetics-market

The deep brain stimulation segment is expected to hold a significant share of the global neuroprosthetics market. The segmental growth is attributed to the increase in number of people with Parkinson’s disease across the globe. 

The Asia-Pacific is expected to be the fastest-growing region during the forecast period owing to increased investment in healthcare technology and infrastructure. Various industry players in the region are launching new products to stay competitive.

Recent Development

• In October 2022, Axoft, a neurotechnology company, launched its Brain-Machine Interface (BMI) to treat neurological disorders better. It was launched through FDA breakthrough device designation. The company secured $8.0 million in capital to fund pre-clinical studies with the FDA and to scale up prototypes of its neural implants.

Market Coverage  

· The market number available for 2023-2031 

· Base year: 2023 

· Forecast period: 2024-2031 

· Segment Covered- 

o By Type

o By Treatment Technique

o By Application

· Regions Covered- 

o North America 

o Europe 

o Asia-Pacific 

o Rest of the World

• Competitive Landscape: Abbott Laboratories, Axonics Modulation Technologies, Inc., Boston Scientific Corp., Medtronic plc, and Oticon Medical among others.

Key questions addressed by the report 

• What is the market's growth rate? 
• Which segment and region dominate the market in the base year? 
• Which segment and region will project the fastest growth in the market? 
• Who is the leader in the market? 
• How are players addressing challenges to sustain growth? 
• Where is the investment opportunity? 

Global Neuroprosthetics Market Report Segment 

By Type 

• Motor Prosthetics
• Sensory Prosthetics
• Cognitive Prosthetics
• Visual Prosthetics

By Treatment Technique

• Deep Brain Stimulation (DBS)
• Vagus Nerve Stimulation (VNS)
• Sacral Nerve Stimulation (SNS)
• Spinal Cord Stimulation (SCS)

By Application

• Motor Disorder
• Physiological Disorder
• Cognitive Disorder

Global Neuroprosthetics Market Report Segment by Region 

North America 

· United States 

· Canada 

Europe 

· UK 

· Germany 

· Italy 

· Spain 

· France 

· Rest of Europe 

Asia-Pacific 

· China 

· India 

· Japan 

· South Korea 

· Rest of Asia-Pacific 

Rest of the World 

· Latin America

· Middle East and Africa

 To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/neuroprosthetics-market